Search research articles
Contact Us
Filters
Showing results (371-380 of 520) with videos related to
Page
of 52
Sort By:
Journal of Nuclear Medicine Technology
|
July 10, 2021
Correlation of Lesional Uptake Parameters and Ratios with miPSMA Score and Estimating Normal Physiologic Concentration: An Exploratory Analysis in Metastatic Castration-Resistant Prostatic Carcinoma Patients with <sup>68</sup>Ga-PSMA-11 PET/CT
Ashwini Kalshetty, Biju Menon, Sutapa Rakshit, et al.
World Journal of Radiology
|
January 16, 2013
Potential of (18)F-FDG-PET as a valuable adjunct to clinical and response assessment in rheumatoid arthritis and seronegative spondyloarthropathies
Vishu Vijayant, Manjit Sarma, Hrushikesh Aurangabadkar, et al.
Molecular Imaging and Biology
|
November 15, 2007
Implications of standardized uptake value measurements of the primary lesions in proven cases of breast carcinoma with different degree of disease burden at diagnosis: does 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography predict tumor biology?
Sandip Basu, Ayse Mavi, Tevfik Cermik, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
July 17, 2013
Gratifying clinical experience with an indigenously formulated single-vial lyophilized HYNIC-TOC kit at the radiopharmaceutical division of BARC: a pivotal boost for building up a peptide receptor radionuclide therapy programme in an Indian setting
Sandip Basu, Purushottam Kand, Madhav Mallia, et al.
The Indian Journal of Chest Diseases & Allied Sciences
|
August 29, 2018
Potential Clinical Utility of FDG-PET in Non-malignant Pulmonary Disorders: A Pilot Study
Makaresh Yadav, Vinaya S Karkhanis, Sandip Basu, et al.
PET Clinics
|
June 18, 2022
Molecular Imaging Assessment of Hormonally Sensitive Breast Cancer: An Appraisal of 2-[18F]-Fluoro-2-Deoxy-Glucose and Newer Non-2-[18F]-Fluoro-2-Deoxy-Glucose PET Tracers
Divya Yadav, Rakesh Kumar, Ankita Phulia, et al.
Expert Opinion on Medical Diagnostics
|
March 16, 2013
Imaging for the diagnosis of thyroid cancer
Muammer Urhan, Murat Velioglu, Joshua Rosenbaum, et al.
Hellenic Journal of Nuclear Medicine
|
December 11, 2012
Aggressive poorly differentiated adenocarcinoma of the lung diagnosed 13 months after initial diagnosis of papillary thyroid carcinoma with "non-iodine concentrating" pulmonary metastasis
Sandip Basu, Bharat Rekhi, Shamim A Shamim, et al.
Clinical Nuclear Medicine
|
August 22, 2007
Intercostal muscle contraction or rib bone marrow activity?: Look for ancillary clues
Sandip Basu, Saad Alzeair, Geming Li, et al.
Hellenic Journal of Nuclear Medicine
|
April 23, 2011
Bilateral renal metastases from papillary thyroid carcinoma on post 131I treatment scan: flip-flop sign, radioiodine SPET, 18F-FDG PET, CECT and histopathological correlation
Chaitanya Borde, Sandip Basu, Purushottam Kand, et al.
Page
of 52
Search research articles
Search
Showing results (371-380 of 520) with videos related to
Sort By:
Page
of 52
Journal of Nuclear Medicine Technology
|
July 10, 2021
Correlation of Lesional Uptake Parameters and Ratios with miPSMA Score and Estimating Normal Physiologic Concentration: An Exploratory Analysis in Metastatic Castration-Resistant Prostatic Carcinoma Patients with <sup>68</sup>Ga-PSMA-11 PET/CT
Ashwini Kalshetty, Biju Menon, Sutapa Rakshit, et al.
World Journal of Radiology
|
January 16, 2013
Potential of (18)F-FDG-PET as a valuable adjunct to clinical and response assessment in rheumatoid arthritis and seronegative spondyloarthropathies
Vishu Vijayant, Manjit Sarma, Hrushikesh Aurangabadkar, et al.
Molecular Imaging and Biology
|
November 15, 2007
Implications of standardized uptake value measurements of the primary lesions in proven cases of breast carcinoma with different degree of disease burden at diagnosis: does 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography predict tumor biology?
Sandip Basu, Ayse Mavi, Tevfik Cermik, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
July 17, 2013
Gratifying clinical experience with an indigenously formulated single-vial lyophilized HYNIC-TOC kit at the radiopharmaceutical division of BARC: a pivotal boost for building up a peptide receptor radionuclide therapy programme in an Indian setting
Sandip Basu, Purushottam Kand, Madhav Mallia, et al.
The Indian Journal of Chest Diseases & Allied Sciences
|
August 29, 2018
Potential Clinical Utility of FDG-PET in Non-malignant Pulmonary Disorders: A Pilot Study
Makaresh Yadav, Vinaya S Karkhanis, Sandip Basu, et al.
PET Clinics
|
June 18, 2022
Molecular Imaging Assessment of Hormonally Sensitive Breast Cancer: An Appraisal of 2-[18F]-Fluoro-2-Deoxy-Glucose and Newer Non-2-[18F]-Fluoro-2-Deoxy-Glucose PET Tracers
Divya Yadav, Rakesh Kumar, Ankita Phulia, et al.
Expert Opinion on Medical Diagnostics
|
March 16, 2013
Imaging for the diagnosis of thyroid cancer
Muammer Urhan, Murat Velioglu, Joshua Rosenbaum, et al.
Hellenic Journal of Nuclear Medicine
|
December 11, 2012
Aggressive poorly differentiated adenocarcinoma of the lung diagnosed 13 months after initial diagnosis of papillary thyroid carcinoma with "non-iodine concentrating" pulmonary metastasis
Sandip Basu, Bharat Rekhi, Shamim A Shamim, et al.
Clinical Nuclear Medicine
|
August 22, 2007
Intercostal muscle contraction or rib bone marrow activity?: Look for ancillary clues
Sandip Basu, Saad Alzeair, Geming Li, et al.
Hellenic Journal of Nuclear Medicine
|
April 23, 2011
Bilateral renal metastases from papillary thyroid carcinoma on post 131I treatment scan: flip-flop sign, radioiodine SPET, 18F-FDG PET, CECT and histopathological correlation
Chaitanya Borde, Sandip Basu, Purushottam Kand, et al.
Page
of 52